We are engaged in a wide range of cutting-edge research areas, including discovery and confirmation of drug target/biomarker, pharmacological effect and mechanism, antibody/protein/polypeptide based biopharmaceuticals, new technology and method in drug development. The research field involves cardiovascular diseases, cancer, neurological and neuropsychiatric diseases, immune system diseases and virus infection.